Details for New Drug Application (NDA): 205648
✉ Email this page to a colleague
NDA 205648 describes PALONOSETRON HYDROCHLORIDE, which is a drug marketed by Accord Hlthcare, Avet Lifesciences, Baxter Hlthcare Corp, Chartwell Rx, Cipla, Dr Reddys, Eugia Pharma, Fresenius Kabi Usa, Hospira, Meitheal, Mylan Institutional, Novast Labs, Qilu Pharm Hainan, Sagent Pharms Inc, Sandoz, Teva Pharms Usa, and Hikma, and is included in twenty NDAs. It is available from sixteen suppliers. Additional details are available on the PALONOSETRON HYDROCHLORIDE profile page.
The generic ingredient in PALONOSETRON HYDROCHLORIDE is palonosetron hydrochloride. There are twenty-one drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the palonosetron hydrochloride profile page.
The generic ingredient in PALONOSETRON HYDROCHLORIDE is palonosetron hydrochloride. There are twenty-one drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the palonosetron hydrochloride profile page.
Summary for 205648
| Tradename: | PALONOSETRON HYDROCHLORIDE |
| Applicant: | Qilu Pharm Hainan |
| Ingredient: | palonosetron hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 205648
| Mechanism of Action | Serotonin 3 Receptor Antagonists |
Suppliers and Packaging for NDA: 205648
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| PALONOSETRON HYDROCHLORIDE | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 205648 | ANDA | Apotex Corp. | 60505-6193 | 60505-6193-1 | 1 VIAL in 1 CARTON (60505-6193-1) / 5 mL in 1 VIAL |
| PALONOSETRON HYDROCHLORIDE | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 205648 | ANDA | Apotex Corp. | 60505-6193 | 60505-6193-4 | 10 VIAL in 1 CARTON (60505-6193-4) / 5 mL in 1 VIAL |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAVENOUS | Strength | EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) | ||||
| Approval Date: | Sep 19, 2018 | TE: | AP | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INTRAVENOUS | Strength | EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML) | ||||
| Approval Date: | Sep 19, 2018 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
